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	 The	 reaction	 of	 N,N'‐(1,4‐phenylene)bis(2‐cyanoacetamide)	 (1)	 with	 phenyl	 isothiocyanate
gave	thiocarbamoyl	derivative	3,	which	reacted	with	α‐halocarbonyl	compounds	in	a	mixture
of	ethanol:N,N‐dimethylformamide	in	the	presence	of	triethylamineto	afford	thiazoles	4,	7,	10
and	 thiophene12	 derivatives.	 While,	 when	 the	 same	 reaction	 was	 refluxed	 in	 a	 mixture	 of
ethanol:N,N‐dimethylformamide	only	afforded	the	acyclic	compounds	5,	6,	8,	9	and	11,	which
when	 refluxed	 in	 N,N‐dimethylformamide	 in	 presence	 of	 triethylamine	 gave	 the
corresponding	above	thiazole	and	thiophene	derivatives.	Moreover,	the	reaction	of	compound
3	 with	 dihalo	 compounds	 afforded	 cyclic	 dithio	 derivatives	 13a,	 13b	 and	 14.	 The	 newly
synthesized	compounds	were	characterized	by	analytical,	spectral	data	and	evaluation	of	their
antimicrobial	activities	of	4,	7,	14	and	15	have	a	high	antimicrobial	activity.	
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1.	Introduction	
	
Aryl	 isothiocyanates	 are	versatile	 reagents	 that	have	been	
used	 as	 synthetic	 intermediates	 to	 prepare	 biologically	 active	
heterocyclic	 compounds	 [1].	 The	 diversity	 of	 biological	 and	
physiological	 activities	 of	 several	 organic	 sulfur	 heterocycles	
may	 be	 attributed	 to	 the	 presence	 of	 the	 N=C=S	 fragment,	
characteristic	 of	 thiazoles,	 thiazolines	 and	 thiazolidines	 [2].	
These	 are	 known	 to	 exhibit	 pesticidal	 [3],	 anticonvulsant	 [4],	
nematocidal	 [5],	 herbicidal	 [6],	 antiviral	 [7],	 fungicidal	 [8],	
bactericidal	[9,10],	antiprotozal	[11],	and	hypoglycemic	activity	
[12].	 They	 are	 also	 act	 as	 chemotherapeutic	 agents.	 This	
encouraged	 us	 to	 design	 a	 specific	 program	 aimed	 at	 the	
synthesis	of	several	new	derivatives	of	these	ring	systems.	
The	present	work	outlines	the	chemistry	of	thiocarbamoyl	
derivatives	not	 all	 but	 the	most	 important	 in	 the	 synthesis	 of	
heterocyclic	 compounds.	 The	 vast	 majority	 of	 thiocarbamoyl	
derivatives	 have	 been	 the	 subject	 of	 many	 studies,	 for	 the	
preparation	 of	 potentially	 biologically	 active	 compounds	 and	
for	some	industrial	uses	[13‐15].	In	this	work,	the	utility	of	the	
title	compounds	in	heterocyclic	synthesis	has	been	studied.	
We	have	been	particularly	 interested	 to	 study	 if	 reactions	
of	 such	 thiocarbamoyl	 might	 be	 extended	 to	 include	 a	 more	
general	synthesis	of	other	classes	of	organic	compounds	and	its	
utility	 as	 synthetic	 intermediate	 for	 the	 synthesis	 of	 new	
heterocyclic	 compounds.	 The	 present	 work,	 reports	 on	 the	
synthesis	of	several	new	thiazole	and	thiophene	derivatives	by	
the	 reaction	 of	 thiocarbamoyl	 of	 the	 type	 3	 with	 compounds	
containing	an	active	methylene	group	in	the	presence	of	a	base.	
Reactions	 of	 this	 type	have	not	been	 reported	previously,	 but	
were	found	to	give	products	in	excellent	yields	under	very	mild	
conditions.	
Moreover,	in	continuation	of	the	previously	reported	work	
[16,17]	 the	 resulting	 thiazole	 and	 thiophene	 derivatives	 have	
latent	functional	substituents,	which	have	potential	for	further	
chemical	 transformations	 and	new	 routes	 for	 the	 preparation	
of	 substituted	 thiazole	 and	 thiophene	 derivatives.	 Now,	 we	
have	 extended	 our	 synthetic	 program	 to	 the	 synthesis	 of	
otherwise	 inaccessible	 heterocyclic	 ring	 system,	 utilizing	
phenyl	 isothiocyanate	 as	 a	 key	 starting	 material.	 It	 is	 known	
that	 a	 great	 variety	 of	 reactants	 bearing	 the	 N=C=S	 fragment	
undergo	 cyclization	 on	 reaction	 with	 α‐halocarbonyl	
compounds	to	afford	thiophenes	[18‐22],	thiazoles,	2,3‐dihydro	
thiazoles	 [4],	which	have	been	shown	 to	exhibit	 antiprotozoal	
[11],	and	fungicidal	properties	[8].	
	
2.	Experimental	
	
2.1.	Instrumentation		
	
All	 melting	 points	 are	 recorded	 on	 Gallenkamp	 electric	
melting	point	apparatus	and	are	uncorrected.	
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Scheme	1	
	
	
The	 IR	 spectra	 (KBr)	 were	 recorded	 on	 Perkin	 Elmer	
Infrared	Spectrophotometer	Model	157,	Grating.	The	1H	and1	3C	
NMR	 spectra	 were	 run	 on	 Varian	 Spectrophotometer	 at	 300	
and	75	MHz,	respectively,	using	tetramethylsilane	(TMS)	as	an	
internal	 reference	 and	DMSO‐d6	 as	 solvent.	 The	mass	 spectra	
(EI)	were	recorded	on	70	eV	with	Kratos	MS	equipment	and/or	
a	 Varian	 MAT	 311	 A	 spectrometer.	 Elemental	 analyses	 (C,	 H	
and	N)	were	carried	out	at	the	micro	analytical	center	of	Cairo	
University,	 Giza,	 Egypt,	 the	 results	 were	 found	 to	 in	 good	
agreement	(±0.3%)	with	the	calculated	values.	
	
2.2.	Synthesis		
	
2.2.1.	Synthesis	of	(2z,2'z)‐N,N'‐(1,4‐phenylene)bis(2‐cyano‐
3‐mercapto‐3‐(phenylamino)acrylamide)	(3)	
	
To	a	solution	of	compound	1	(2.4	g,	0.01	mol),	 in	DMF	(30	
mL),	and	phenyl	isothiocyanate	(3	mL,	0.02	mol)	in	presence	of	
NaOEt	 (formed	 from	 0.4g	 Na	 +	 20	 mL	 EtOH),	 was	 stirred	
overnight	 at	 room	 temperature	 to	 give	 compound	 2	 as	 non‐
isolable	salt.	The	reaction	mixture	was	poured	onto	crushed	ice	
and	neutralized	by	dilute	HCl.	The	obtained	solid	product	was	
collected	 by	 filtration,	 washed,	 dried	 and	 crystallized	 from	
ethanol	to	give	compound	3	(Scheme	1).	Color:	Green	powder.	
Yield:	90%.	M.p.:198	°C.	 IR	 (KBr,	ν,	 cm‐1):	3291	(NHCO),	3043	
(NHPh),	 2185	 (CN),	 1593	 (C=O),	 1233	 (C=S).	 1H	 NMR	 (300	
MHz,	 DMSO‐d6,	 δ,	 ppm):	 3.84	 (s,	 2H,	 ‐2SH‐),	 4.25	 (s,	 2H,	
2NHPh),	 7.02‐7.78	 (m,	 14H,	 Ar‐H),	 9.75	 (s,	 2H,	 2NHCO).	 13C	
NMR	(75	MHz,	DMSO‐d6,	δ,	ppm):	171	(2C,	C‐SH),	161	(2C,	CO),	
138	(2C,	Ar‐C),	133	(2C,	Ar‐C),	131	(2C,	Ar‐C),	129	(2C,	Ar‐C),	
126	(2C,	Ar‐C),	124	(2C,	Ar‐C),	123	(2C,	Ar‐C),	120	(4C,	Ar‐C),	
118	(2C,	CN),	88	(2C,	C‐CN).	LC‐MS	(m/z,	%):	512	(M+,	58),	470	
(58),	 462	 (56),	 349	 (96),	 333	 (42),	 273	 (47),	 226	 (87),	 206	
(100),	200	(89),	174	(33),	136	(17),	115	(48),	94	(56),	65	(43),	
52	 (26).	 Anal.	 calcd.	 for	 C26H20N6O2S2	 (512.11):	 C,	 60.92;	 H,	
3.93;	 N,	 16.39;	 O,	 6.24;	 S,	 12.51.	 Found:	 C,	 60.85;	 H,	 3.90;	 N,	
16.46;	O,	6.26;	S,	12.52%.	
	
2.2.2.	Synthesis	of	(2z,2'z)‐N,N'‐(1,4‐phenylene)bis(2‐cyano‐
2‐(3,4‐diphenylthiazol‐2(3H)‐ylidene)acetamide)	(4)	
	
Method	A	:	A	solution	of	compound	3	(5.12	g,	0.01	mol),	in	a	
mixture	of	EtOH:DMF	(2:1,	v:v)	(30	mL),	and	phenacyl	bromide	
(4	 g,	 0.02	 mol),	 in	 presence	 of	 triethylamine	 (4	 drops),	 was	
refluxed	 for	 4	 h.	 The	 reaction	 mixture	 was	 allowed	 to	 cool,	
poured	 onto	 crushed	 ice.	 The	 obtained	 solid	 product	 was	
collected	 by	 filtration,	 washed,	 dried	 and	 crystallized	 from	
ethanol	to	give	compound	4	(Scheme	2).	
Method	B:	A	solution	of	compound	5	 (7.48	g,	0.01	mol),	 in	
DMF	 (30	 mL),	 in	 presence	 of	 triethylamine	 (4	 drops),	 was	
refluxed	 4	 h.	 The	 reaction	mixture	 was	 poured	 onto	 crushed	
ice.	 The	 obtained	 solid	 product	 was	 collected	 by	 filtration,	
washed,	dried	and	crystallized	from	ethanol	to	give	compound	
4.	
(2z,2'z)‐N,N'‐(1,4‐phenylene)bis(2‐cyano‐2‐(3,4‐diphenyl	
thiazol‐2(3H)‐ylidene)acetamide)	 (4):	 Color:	 Brown	 powder.	
Yield:	 90%.	 M.p.:	 272	 °C.	 IR	 (KBr	 ν/cm‐1):	 3284	 (NH),	 3054	
(CH2),	2170	(CN),	1581	(CONH),	1552	(C=C).	1HNMR	(300	MHz,	
DMSO‐d6,	 δ,	 ppm):	 6.23	 (s,	 2H,	 2CHthiazole),	 7.23‐7.45	 (m,	 20H,	
Ar‐H),	7.33‐7.46	(dd,	4H,	Ar‐H	AB	system),	9.50	(s,	2H,	2NHCO).	
LC‐MS	(m/z,	%):	712	(M+,	2),	689	(2),	454	(2),	428	(5),	368	(7),	
343	 (5),	 319	 (8),	 294	 (95),	 276	 (24),	 217	 (24),	 134	 (31),	 77	
(100).	Anal.	 calcd.	 forC42H28N6O2S2	 (712.17):	C,	70.77;	H,	3.96;	
N,	11.79;	O,	4.49;	S,	9.00.	Found:	C,	70.69;	H,	4.00;	N,	11.81;	O,	
4.50;	S,	9.01%.	
	
2.2.3.	Synthesis	of	(2Z,2'Z)‐N,N'‐(1,4‐phenylene)bis(2‐cyano‐
3‐((2‐oxo‐2‐phenylethyl)thio)‐3‐(phenylamino)acrylamide)	
(5),	(2Z,2'Z)‐N,N'‐(1,4‐phenylene)bis(2‐cyano‐3‐((cyano	
methyl)thio)‐3‐(phenylamino)acrylamide)	(9)	and	(2Z,2'Z)‐
N,N'‐(1,4‐phenylene)bis(2‐cyano‐3‐((2‐oxopropyl)thio)‐3‐
(phenylamino)acrylamide)	(11)		
	
General	procedure	:	A	solution	of	compound	2	(0.01	mol),	in	
a	 mixture	 of	 EtOH:DMF	 (2:1,	 v:v)	 (30	 mL),	 and	 phenacyl	
bromide	 (4	g,	0.02	mol)	and/or	chloroacetonitrile	 (1.4	g,	 0.02	
mol)	and/or	chloroacetone	(1.5	g,	0.02	mol)	was	stirred	4‐6	h.	
The	 reaction	 mixture	 was	 poured	 onto	 crushed	 ice.	 The	
obtained	 solid	 product	 was	 collected	 by	 filtration,	 washed,	
dried	and	crystallized	from	ethanol	to	give	compounds	5,	9	and	
11,	respectively	(Scheme	2).	
(2Z,2'Z)‐N,N'‐(1,4‐phenylene)bis(2‐cyano‐3‐((2‐oxo‐2‐phenyl	
ethyl)thio)‐3‐(phenylamino)acrylamide)	 (5):	 Color:	 Yellow	
powder.	Yield:	30%.	M.p.:	185	°C.	IR	(KBr,	ν,	cm‐1):	3295	(NH),	
2925	 (CH2),	 2186	 (CN),	 1649	 (CONH),	 1599	 (C=C).	 1HNMR	
(300MHz,	DMSO‐d6,	δ,	ppm):	3.72	(s,	2H,	2NHPh),	4.30	(s,	4H,	
2CH2),	 7.23‐7.62	 (m,	 20H,	 Ar‐H),	 7.31‐7.45	 (dd,	 4H,	 Ar‐H	 AB	
system),	9.70	(s,	2H,	2NHCO).		
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Scheme	2	
	
	
13C	NMR	(75	MHZ,	DMSO‐d6,	δ,	ppm):192	(2C,	CO‐Ph),	171	
(2C,	C‐S),	162	(2C,	CO‐NH),	136	(4C,	Ar‐C),	133	(4C,	Ar‐C),	129	
(4C,	Ar‐C),	126	(4C,	Ar‐C),	124	(4C,	Ar‐C),	123	(4C,	Ar‐C),	122	
(2C,	Ar‐C),	120	(4C,	Ar‐C),	118	(2C,	CN),	71	(2C,	C‐CN),	38	(2C,	
CH2‐S).	 LC‐MS	 (m/z):	 748	 (M+,	 20),	 746	 (4)	 713	 (4),	 680	 (4),	
391	(4),	327	(6),	276	(36),	172	(11),	135	(19),	77	(100).	Anal.	
calcd.	for	C42H32N6O4S2	(748.19):	C,	67.36;	H,	4.31;	N,	11.22;	O,	
8.55;	 S,	 8.56.	 Found:	 C,	 67.38;	 H,	 4.26;	 N,	 11.24;	 O,	 8.54;	 S,	
8.58%.	
(2Z,2'Z)‐N,N'‐(1,4‐phenylene)bis(2‐cyano‐3‐((cyanomethyl)	
thio)‐3‐(phenylamino)acrylamide)	 (9):	 Color:	 Yellow	 powder.	
Yield:	 20%.	 M.p.:	 215	 °C.	 IR	 (KBr,	 ν,	 cm‐1):	 3407	 (NH),	 2923	
(CH2),	2193	(CN),	1656	(CONH),	1606(C=C).	1HNMR	(300	MHz,	
DMSO‐d6,	δ,	ppm):	4.00	(s,	2H,	2NHPh),	4.11	(s,	4H,	2CH2),	7.02‐
7.71	 (m,	 14H,	 Ar‐H),	 9.70	 (s,	 2H,	 2NHCO).	 LC‐MS	 (m/z):	 590	
(M+,	 15),	 591	 (4),	 524	 (2),	 376	 (17),	 350	 (12),	 243	 (33),	 215	
(71),	169	(16),	132	(31),	77	(100).	Anal.	calcd.	for	C30H22N8O2S2	
(590.13):	C,	61.00;	H,	3.75;	N,	18.97;	O,	5.42;	S,	10.86.	Found:	C,	
60.94;	H,	3.73;	N,	18.99;	O,	5.45;	S,	10.89%.	
(2Z,2'Z)‐N,N'‐(1,4‐phenylene)bis(2‐cyano‐3‐((2‐oxopropyl)	
thio)‐3‐(phenylamino)acrylamide)	 (11):	 Color:	 Yellow	 powder.	
Yield:	 60%.	 M.p.:	 154°C.	 IR	 (KBr,	 ν,	 cm‐1):	 3279	 (NH),	 2924	
(CH2),	 2184	 (CN),	 1723	 (COCH3),	 1644	 (CONH).	 1H	NMR	 (300	
MHz,	DMSO‐d6,	 δ,	 ppm):	 2.10	 (s,	 6H,	 2CH3),	 3.45	 (s,4H,	2CH2),	
4.00	 (s,	 2H,	 2NHph),	 7.36‐7.59	 (m,	 14H,	 Ar‐H),	 9.76	 (s,	 2H,	
2NHCO).	 13C	 NMR	 (75	 MHZ,	 DMSO‐d6,	 δ,	 ppm):200	 (2C,	 CO‐
CH3),	171	(2C,	C‐S),	161	(2C,	CO‐NH),	139	(2C,	Ar‐C),	133	(2C,	
Ar‐C),	129	(4C,	Ar‐C),	126	(2C,	Ar‐C),	124	(2C,	Ar‐C),	123	 (2C,	
Ar‐C),	120	(4C,	Ar‐C),	118	(2C,	CN),	71	(2C,	C‐CN),	38	(2C,	CH2‐
S),	26	(2C,	CH3).	LC‐MS	(m/z):	624	(M+,	9),	338	(9),	277	(4),	257	
(7),	243	(11),	232	(83),	217	(10),	201	(5),	189	(16),	150	(12),	
135	 (19),	 108	 (46),	 93	 (40),	 86	 (63),	 77	 (70).	 Anal.	 calcd.	 for	
C32H28N6O4S2	 (623.17):	C,	63.54;	H,	4.69;	N,	11.23;	O,	10.26;	S,	
10.28.	Found:	C,	63.45;	H,	4.73;	N,	11.25;	O,	10.27;	S,	10.30%.	
	
2.2.4.	Synthesis	of	diethyl	2,2'‐(((1Z,1'Z)‐(1,4‐phenylene	
bis(azanediyl))bis(2‐cyano‐3‐oxo‐1‐(phenylamino)prop‐1‐
ene‐3,1‐diyl))bis(sulfanediyl))diacetate	(6)	and	2,2'‐(((1Z,	
1'Z)‐(1,4‐phenylenebis(azanediyl))bis(2‐cyano‐3‐oxo‐1‐
(phenylamino)prop‐1‐ene‐3,1‐diyl))bis(sulfanediyl))diacetyl	
chloride	(8)	
	
To	 a	 solution	 of	 compound	2	 (0.01	mol),	 in	 a	 mixture	 of	
EtOH:DMF	(2:1,	v:v)	(30	mL),	ethyl	chloroacetate	(1.75	mL,	0.02	
mol)	or	ethyl	bromoacetate	(2.3	mL,	0.02	mol)	or	chloroacetic	
acid	(1.35	mL,	0.02	mol)	or	chloroacetyl	chloride	(1.6	mL,	0.02	
mol)was	 added	 and	 stirred	 for	 4	 h	 at	 room	 temperature.	 The	
reaction	 mixture	 was	 then	 poured	 onto	 crushed	 ice.	 The	
obtained	 solid	 product	 was	 collected	 by	 filtration,	 washed,	
dried	and	crystallized	from	ethanol	to	give	compounds	6	and	8,	
respectively	(Scheme	3).	
Diethyl	 2,2'‐(((1Z,1'Z)‐(1,4‐phenylenebis(azanediyl))bis(2‐
cyano‐3‐oxo‐1‐(phenylamino)prop‐1‐ene‐3,1‐diyl))bis(sulfane	
diyl))diacetate	(6):	Color:	Brown	powder.	Yield:	90%.	M.p.:	272	
°C.	IR	(KBr,	ν,	cm‐1):	3401	(NHPh),	3322	(NH),	2200	(CN),	1735	
(COOEt),	1660	(CONH),	1594	(C=C).	1H	NMR	(300	MHz,	DMSO‐
d6,	δ,	ppm):	1.21	(t,	6H,	2CH3),	3.92	(s,	2H,	2NHPh),4.00	(s,	4H,	
2CH2S),	 4.18	 (q,	 4H,	 2CH2),	 7.06‐7.61	 (m,	 14H,	 Ar‐H),	 9.69	 (s,	
2H,	2NHCO).	LC‐MS	(m/z):	684	(M+,	73),	682	(86),	677(96),	669	
(92),	602	(59),	571	(57),	507	(44),	496	(40),	422	(16),	376	(18),	
350	(14),	288	(8),	262	(61)	,	242	(20),	215	(76),	190	(44),	169	
(9),150	 (100),	143	 (55),	 122	 (20),	 117	 (55),	 92	 (64),	 78	 (98),	
65(69)	 ,	 51	 (90).	 Anal.	 calcd.	 for	 C34H32N6O6S2	 (684.18):	 C,	
59.63;	H,	4.71;	N,	 12.27;	O,	 14.02;	 S,	 9.36.	 Found:	 C,	 59.59;	H,	
4.65;	N,	12.33;	O,	14.04;	S,	9.38%.		
2,2'‐(((1Z,1'Z)‐(1,4‐phenylenebis(azanediyl))bis(2‐cyano‐3‐
oxo‐1‐(phenylamino)prop‐1‐ene‐3,1‐diyl))bis(sulfanediyl))	
diacetyl	 chloride	 (8):	 Color:	 Orange	 powder.	 Yield:	 50%.	M.p.:	
160	°C.	IR	(KBr,	ν,	cm‐1):	3408	(NHPh),	3318	(NH),	2922	(CH2),	
2194	 (CN),	 1745	 (COCl),	 1655	 (CONH).	 1H	 NMR	 (300	 MHz,	
DMSO‐d6,	 δ,	 ppm):	 3.82	 (s,	 2H,	 2NHPh),	 4	 (s,	 4H,	 2CH2),	 7.20‐
7.63	 (m,	 14H,	 Ar‐H),	 9.55	 (s,	 2H,	 2NHCO).	 LC‐MS	 (m/z):	 664	
(M+,	23),	525	(1),	417	(23),	350	(11),	243	(46),	215	(92),	169	
(18),	 132	 (42),	 107	 (46),	 77	 (100).	 Anal.	 calcd.f	 or	
C30H22N6O4S2Cl2	(664.05):	C,	54.14;	H,	3.33;	Cl,	10.65;	N,	12.63;	
O,	9.62;	S,	9.64.	Found:	C,	54.09;	H,	3.30;	Cl,	10.69;	N,	12.65;	O,	
9.63;	S,	9.65%.	
	
2.2.5.	Synthesis	of	(2z,2'z)‐N,N'‐(1,4‐phenylene)bis(2‐cyano‐
2‐(4‐oxo‐3‐phenylthiazolidin‐2‐ylidene)acetamid)	(7)	
	
Method	A:	A	solution	of	compound	3	(5.12	g,	0.01	mol),	in	a	
mixture	 of	 EtOH:DMF	 (2:1,	 v:v)	 (30	 mL),	 and	 chloroacetyl	
chloride	 (1.6	 mL,	 0.02	mol)	 and/or	 ethyl	 chloroacetate	 (1.75	
mL,	 0.02	mol)	 and/or	 ethyl	 bromoacetate	 (2.3	mL,	 0.02	mol)	
and/or	chloroacetic	acid	(1.35	mL,	0.02	mol),	in	the	presence	of	
triethylamine	(4	drops),	was	refluxed	for	4	h	(Scheme	3).		
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Scheme	3	
	
	
The	 reaction	 mixture	 was	 allowed	 to	 cool,	 poured	 onto	
crushed	 ice.	 The	 obtained	 solid	 product	 was	 collected	 by	
filtration,	washed,	 dried	 and	 crystallized	 from	 ethanol	 to	 give	
compound	7.	
Method	 B:	 A	 solution	 of	 compound	 6	 or	 8	 (0.01	 mol),	 in	
DMF	 (30	 mL),	 in	 presence	 of	 triethylamine	 (4	 drops),	 was	
refluxed	 4	 h.	 The	 reaction	mixture	 was	 poured	 onto	 crushed	
ice.	 The	 obtained	 solid	 product	 was	 collected	 by	 filtration,	
washed,	dried	and	crystallized	from	ethanol	to	give	compound	
7.	
(2z,2'z)‐N,N'‐(1,4‐phenylene)bis(2‐cyano‐2‐(4‐oxo‐3‐phenyl	
thiazolidin‐2‐ylidene)acetamid)	 (7):	 Color:	 Brown	 powder.	
Yield:	 90%.	 M.p.:	 247	 °C.	 IR	 (KBr,	 ν,	 cm‐1):	 3401	 (NH),	 2194	
(CN),	1735	(CO),	1656	(CONH).	1H	NMR	(300	MHzZ,	DMSO‐d6,	
δ,	 ppm):	 3.97	 (s,	 4H,	2CH2),	7.23‐7.55	 (m,	14H,	Ar‐H),	9.28	 (s,	
2H,	 2NHCO).	 LC‐MS	 (m/z):	 592	 (M+,	 2),	 458	 (2),	 448	 (4),	 431	
(2),	422	(6),	404	 (2),	375	(8),	350	(9),	271	 (4),	215	(35),	143	
(28),	134	(42),	93	(59),	77	(100).	Anal.	calcd.	for	C30H20N6O4S2	
(592.10):	C,	60.80;	H,	3.40;	N,	14.18;	O,	10.80;	S,	10.82.	Found:	
C,	60.74;	H,	3.42;	N,	14.20;	O,	10.78;	S,	10.86%.	
	
2.2.6.	Synthesis	of	(2Z,2'Z)‐N,N'‐(1,4‐phenylene)bis(2‐(4‐
amino‐3‐phenylthiazol‐2(3H)‐ylidene)‐2‐cyanoacetamide)	
(10)	
	
Method	A:	A	solution	of	compound	3	(5.12	g,	0.01	mol)	in	a	
mixture	of	EtOH:DMF	(2:1,	v:v)	(30	mL)	containing	few	drops	of	
triethylamine	 (4	 drops)	 was	 treated	 with	 chloroacetonitrile	
(1.4	g,	0.02	mol).	The	reaction	mixture	was	refluxed	for	6	h,	and	
allowed	to	cool,	poured	onto	crushed	ice.	The	solid	product	was	
collected	 by	 filtration,	 washed,	 dried	 and	 crystallized	 from	
ethanol	to	give	compound	10	(Scheme	4).	
Method	B:	 A	 solution	 of	 compound	9	 (5.9	 g,	 0.01	mol),	 in	
DMF(30	 mL),	 in	 presence	 of	 triethylamine	 (4	 drops),	
wasrefluxed	 6	 h.	 The	 reaction	 mixture	 was	 poured	 onto	
crushed	 ice.	 The	 obtained	 solid	 product	 was	 collected	 by	
filtration,	washed,	 dried	 and	 crystallized	 from	 ethanol	 to	 give	
compound	10.	
(2Z,2'Z)‐N,N'‐(1,4‐phenylene)bis(2‐(4‐amino‐3‐phenyl	
thiazol‐2(3H)‐ylidene)‐2‐cyanoacetamide)	 (10):	 Color:	 Green	
powder.	Yield:	78%.	M.p.:	270	°C.	IR	(KBr,	ν,	cm‐1):	3399	(NH),	
2197	 (CN),	 1650	 (CO).	 1HNMR	 (300	 MHz,	 DMSO‐d6,	 δ,	 ppm):	
1.21	(s,	4H,	2NH2),	4.11	(s,	2H,	2CH),	7.02‐7.56	(m,	14H,	Ar‐H),	
9.63	(s,	2H,	2NHCO).	LM‐CS	(m/z):	590	 (M+,	10),	538	(2),	451	
(24),	374	(17),	348	(18),	266	(10),	215	(13),	174	(11),	134	(59),	
127	 (12),	 77	 (100).	 Anal.	 calcd.	 for	 C30H22N8O2S	 (590.13):	 C,	
61.00;	H,	3.75;	N,	 18.97;	O,	 5.42;	 S,	 10.86.	 Found:	 C,	 60.95;	H,	
3.77;	N,	18.95;	O,	5.45;	S,	10.88%.	
	
2.2.7.	Synthesis	of	N,N'‐(1,4‐phenylene)bis(5‐acetyl‐4‐amino‐
2‐(phenylamino)thiophene‐3‐carboxamide)	(12)	
	
Method	A:	A	solution	of	compound	3	(5.12	g,	0.01	mol)	in	a	
mixture	of	EtOH:DMF	(2:1,	v:v)	(30	mL)	containing	few	drops	of	
triethylamine	(4	drops)	was	treated	with	chloroacetone	(1.5	g,	
0.02	mol).	The	reaction	mixture	was	refluxed	for	4h,	allowed	to	
cool,	poured	onto	crushed	ice.	The	solid	product	was	collected	
by	 filtration,	 washed,	 dried	 and	 crystallized	 from	 ethanol	 to	
give	compound	12	(Scheme	5).	
Method	B:	A	solution	of	compound	11	(6.26g,	0.01	mol),	in	
DMF	 (30	 mL),	 in	 presence	 of	 triethylamine	 (4	 drops),	 was	
refluxed	 4	 h.	 The	 reaction	mixture	 was	 poured	 onto	 crushed	
ice.	 The	 obtained	 solid	 product	 was	 collected	 by	 filtration,	
washed,	dried	and	crystallized	from	ethanol	to	give	compound	
12.	
N,N'‐(1,4‐phenylene)bis(5‐acetyl‐4‐amino‐2‐(phenylamino)	
thiophene‐3‐carboxamide)	 (12):	 Color:	 Brown	 powder.	 Yield:	
70%.	 M.p.:	 234	 °C.	 IR	 (KBr,	 ν,	 cm‐1):	 3270	 (NH),	 2191	 (CN),	
1743	 (COCH3),	 1660	 (CONH).	 1H	NMR	 (300	MHz,	DMSO‐d6,	 δ,	
ppm):	2.50	(s,	6H,	2CH3),	7.11	(s,	4H,	2NH2),	7.36‐7.63	(m,	14H,	
Ar‐H),	9.72	(s,	2H,	2NHPh),	9.78	(s,	2H,	2NHCO).		
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LM‐CS	(m/z):	624	(M+,	9),	376	(2),	350	(4),	338	(9),	277	(4),	
257	(7),	243	(11),	232	(83),	217	(10),	189	(16),	135	(19),	108	
(46),	77	 (70).	Anal.	 calcd.	 for	C32H28N6O4S2	 (624.16):	C,	 61.52;	
H,	4.52;	N,	13.45;	O,	10.24;	S,	10.27.	Found:	C,	61.45;	H,	4.54;	N,	
13.48;	O,	10.25;	S,	10.28%.	
	
2.2.8.	Synthesis	of	(2z,2'z)‐N,N'‐(1,4‐phenylene)bis(2‐cyano‐
3‐(methylthio)‐3‐(phenylamino)acrylamide)derivatives	
(13a,	13b	and	14)	
	
To	a	solution	of	compound	2	(0.01	mol),	in	DMF	(30	mL)	in	
presence	of	 alcoholic	KOH	 (10%)	 (formed	 from	0.56	g	KOH	+	
100	 mL	 EtOH),	 1,3‐dibromopropane	 (2	 mL,	 0.02	 mol)or	 1,4‐
dibromobutane	 (2.2	 mL,	 0.02	 mol)	 or	 1,2‐bis(bromomethyl)	
benzene	(2.6	mL,	0.02	mol)	was	added	and	stirred	overnight	at	
room	 temperature.	 The	 reaction	 mixture	 was	 poured	 onto	
crushed	 ice.	 The	 obtained	 solid	 product	 was	 collected	 by	
filtration,	washed,	 dried	 and	 crystallized	 from	 ethanol	 to	 give	
compounds	13a,	13b,	14,	respectively	(Scheme	6).	
(4Z,11Z)‐3,13‐dioxo‐5,11‐bis(phenylamino)‐6,10‐dithia‐2,14‐
diaza‐1(1,4)‐benzenacyclotetradecaphane‐4,11‐diene‐4,12‐
dicarbonitrile	 (13a):	 Color:	 Green	 powder.	 Yield:	 90%.	 M.p.:	
170	 °C.	 IR	 (KBr,	 ν,	 cm‐1):	 3303	 (NHPh),	 3284	 (NHCO),	 2192	
(CN),	 1660	 (CO).	 1H	NMR	 (300	MHz,	DMSO‐d6,	 δ,	 ppm):	 1.72‐
1.93	 (m,	 2H,	 CH2),	 3.40	 (t,	 4H,	 2CH2S),	 3.68	 (s,	 2H,	 2NHPh),	
7.21‐7.55	 (m,	 14H,	 Ar‐H),	 9.56	 (s,	 2H,	 2NHCO).	 LM‐CS	 (m/z):	
552	(M+,	40),	558	(20),	333	(25),	214	(25),	160	(33),	143	(29),	
125	(37),	106	(37),	99	(29),	93	(83),	79	(41),	76	(79),	60	(100).	
Anal.	 calcd.	 for	 C29H24N6O2S2	 (552.14):	 C,	 63.02;	 H,	 4.38;	 N,	
15.21;	O,	 5.79;	 S,	 11.60.	 Found:	 C,	 62.96;	H,	 4.36;	N,	 15.26;	O,	
5.82;	S,	11.60%.	
(4Z,12Z)‐3,14‐dioxo‐5,12‐bis(phenylamino)‐6,11‐dithia‐2,15‐
diaza‐1(1,4)‐benzenacyclopentadecaphane‐4,12‐diene‐4,13‐
dicarbonitrile	 (13b):	 Color:	 Green	 powder.	 Yield:	 89%.	 M.p.:	
155	 °C.	 IR	 (KBr,	 ν,	 cm‐1):	 3280‐3330	 (NH),	 2194	 (CN),	 1631	
(CO).	 1H	 NMR	 (300	 MHz,	 DMSO‐d6,	 δ,	 ppm):	 1.52‐1.75	 (m,	
4H,2CH2),	 3.40	 (t,	 4H,	 2CH2S),	 4.10	 (s,	 2H,	 2NHPh),	 7.23‐7.43	
(m,	14H,	Ar‐H),	9.41	(s,	2H,	2NHCO).	LM‐CS	(m/z):	566(M+,	18),	
569	(9),	519	(1),	496	(1),	470	(2),	426	(1),	391	(1),	335	(2),	301	
(4),	276	(1),	260	(4),	246	(1),	231	(5),	176	(11),	143	(42),	119	
(25),	 88	 (53),	 77	 (66),	 60	 (100).	 Anal.	 calcd.	 for	 C30H26N6O2S	
(566.16):	C,	63.58;	H,	4.62;	N,	14.83;	O,	5.65;	S,	11.32.	Found:	C,	
63.52;	H,	4.64;	N,	14.85;	O,	5.66;	S,	11.33%.	
(4Z,11Z)‐3,13‐dioxo‐5,11‐bis(phenylamino)‐6,10‐dithia‐2,14‐
diaza‐1(1,4),8(1,2)‐dibenzenacyclotetradecaphane‐4,11‐diene‐
4,12‐dicarbonitrile	(14):	Color:	Green	powder.	Yield:	91%.	M.p.:	
197	 °C.	 IR	 (KBr,	 ν,	 cm‐1):	 3401	 (NHPh),	 3259	 (NHCO),	 2192	
(CN),	1660	(CO).	1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	3.86	(s,	
4H,	 2CH2‐),	 7.14‐7.40	 (m,	 14H,	 Ar‐H),	 7.60	 (d,	 4H,	 Ar‐H,	 AB	
system),	 9.51	 (s,	 2H,	 2NHPh),	 11.65	 (s,	 2H,	 2NHCO).	 LM‐CS	
(m/z):	614	(M+,	7),	578	(5),	169	(24),	141	(19),	135	(24),	126	
(24),	 105	 (38),	 93	 (90),	 80	 (100),	 67	 (47).	 Anal.	 calcd.	 for	
C34H26N6O2S2	 (614.16):	 C,	 66.43;	 H,	 4.26;	 N,	 13.67;	 O,	 5.21;	 S,	
10.43.	Found:	C,	66.36;	H,	4.29;	N,	13.69;	O,	5.24;	S,	11.42%.	
	
2.2.9.	Synthesis	of	(2z,2'z)‐N,N'‐(1,4‐phenylene)bis(2‐cyano‐
3‐(2,6‐diaminopyrimidin‐4‐ylthio)‐3‐(phenylamino)	
acrylamide)	(15)	
	
To	 a	 solution	 of	 compound	 2	 (0.01	mol),	 in	 a	 mixture	 of	
DMF:acetone	 (1:2,	 v:v)	 (30	 mL),	 in	 presence	 of	 potassium	
carbonate	 (1.38	 g,	 0.01	 mol)	 ,	 and	 6‐chloro‐2,4‐diamino	
pyrimidine	 (3	 mL,	 0.02	 mol)	 was	 refluxed	 5	 h.	 The	 reaction	
mixture	 was	 allowed	 to	 cool,	 poured	 onto	 crushed	 ice.	 The	
obtained	 solid	 product	 was	 collected	 by	 filtration,	 washed,	
dried	 and	 crystallized	 from	 ethanol	 to	 give	 compound	 15	
(Scheme	6).	Color:	Green	powder.	Yield:	73%.	M.p.:	155	°C.	 IR	
(KBr,	 ν,	 cm‐1):	 3397	 (NH2),	 3315	 (NH2),	 3282	 (NHPh),	 3195	
(NHCO),	2927	(CH),	2192	(CN),	1644	(CO).	1H	NMR	(300	MHz,	
DMSO‐d6,	 δ,	 ppm):	 4.10	 (s,	 2H,	 2NHPh),	 5.86	 (s,	 2H,	 2CH‐
pyrimidine),	6.55‐6.65	 (sb,	8H,	4NH2),	7.02	 ‐7.50	 (m,	14H,	Ar‐
H),	 9.65	 (s,	 2H,	 2NHCO).	 LM‐CS	 (m/z):	 728	 (M+,	13),	 724	 (2),	
302	 (2),	 235	 (6),	 216	 (3),	 150	 (11),	 135	 (27),	 119	 (27),	 93	
(100),	 77	 (61),	 65	 (36).	 Anal.	 calcd.	 for	 C34H28N14O2S2	
(728.20):C,	56.03;	H,	3.87;	N,	26.91;	O,	4.39;	S,	8.80.	Found:	C,	
55.93;	H,	3.89;	N,	26.95;	O,	4.41;	S,	8.82%.	
	
2.3.	Antimicrobial	studies	
	
The	 disks	 of	 Whatman	 filter	 paper	 were	 prepared	 with	
standard	 size	 (5.0	 mm	 diameter)	 and	 kept	 into	 1.0	 oz	 screw	
capped	 wide	 mouthed	 containers	 for	 sterilization.	 These	
bottles	 are	 kept	 into	 hot	 air	 oven	 at	 temperature	 of	 150	 °C.	
Then,	 the	 standard	 sterilized	 filter	 paper	 disks	 impregnated	
with	a	solution	of	the	test	compound	in	DMF	(1	mg/mL)	were	
placed	on	nutrient	agar	plate	seeded	with	the	appropriate	test	
organism	in	triplicates.		
Fadda	et	al.	/	European	Journal	of	Chemistry	5	(2)	(2014)	296‐304	 301	
 
	
H
N
N
H
O
ONC
CN
SNaPhHN
NaS NHPh
H
N
N
H
O
ONC
CN
SHPhHN
HS NHPh
dil.HCl
H
N
N
H
O
O
NHPh
PhHN
ClCH2COCH3
DMF/ EtOH
H
N
N
H
O
ONC
CN
SPhHN
S NHPh
H3C
O
CH3
O
DMF/TEA
ClCH2COCH3
EtOH/ DMF/ TEA
S
S
H2N
H3COC
COCH3
NH2
2
11
3 12  
	
Scheme	5	
	
	
Standard	 concentrations	 of	 106	 CFU/mL	 (Colony	 Forming	
U/mL)	 and	 104	 CFU/mL	 were	 used	 for	 antibacterial	 and	
antifungal	assay,	respectively.	Pyrex	glass	Petri	dishes	(9	cm	in	
diameter)	 were	 used	 and	 two	 disks	 of	 filter	 paper	 were	
inoculated	 in	 each	 plate.	 The	 utilized	 test	 organisms	were:	B.	
subtilis	 and	 B.	 thuringiensis	 as	 examples	 of	 Gram‐positive	
bacteria	 and	 E.	 coli	 and	 P.	 aeruginosa	 as	 examples	 of	 Gram‐
negative	 bacteria.	 They	were	 also	 evaluated	 for	 their	 in	 vitro	
antifungal	 potential	 against	 F.	 oxysporum	 and	 B.	 fabae	 fungal	
strains.	Chloramphenicol,	cephalothin	and	cycloheximide	were	
used	 as	 standard	 antibacterial	 and	 antifungal	 agents,	
respectively.	DMF	alone	was	used	as	control	at	the	same	above‐
mentioned	 concentration	 and	 due	 this	 there	 was	 no	 visible	
change	in	bacterial	growth.	The	plates	were	incubated	at	37	°C	
for	 24	 h	 for	 bacteria	 and	 for	 48	 h	 for	 fungi.	 Compounds	 that	
showed	significant	growth	inhibition	zones	(>14	mm)	using	the	
twofold	 serial	 dilution	 technique,	 were	 further	 evaluated	 for	
their	minimal	inhibitory	concentrations	(MICs).	
	
2.4.	Minimal	inhibitory	concentration	(MIC)	measurement		
	
The	 microdilution	 susceptibility	 test	 in	 Müller‐Hinton	
Broth	 (Oxoid)	 and	 Sabouraud	 Liquid	 Medium	 (Oxoid)	 were	
used	 for	 the	 determination	 of	 antibacterial	 and	 antifungal	
activity,	respectively.	Stock	solutions	of	the	tested	compounds,	
Chloramphenicol,	 cephalothin	 and	 cycloheximide	 were	
prepared	in	DMF	at	concentration	of	1000	mg/mL.	Each	stock	
solution	was	 diluted	 with	 standard	 method	 broth	 to	 prepare	
serial	 twofold	 dilutions	 in	 the	 range	 of	 500‐3.125	mg/mL	 10	
mL	of	 the	broth	containing	about	106	CFU/mL	of	 test	bacteria	
was	added	to	each	well	of	96‐well	microtiter	plate.	The	sealed	
microplates	were	 incubated	at	37	°C	 for	24	h	for	antibacterial	
activity	and	at	37	°C	for	48	h	for	antifungal	activity	in	a	humid	
chamber.	 At	 the	 end	 of	 the	 incubation	 period,	 the	 minimal	
inhibitory	 concentrations	 (MIC)	 values	 were	 recorded	 as	 the	
lowest	 concentrations	 of	 the	 substance	 that	 had	 no	 visible	
turbidity.	 Control	 experiments	 with	 DMF	 and	 uninoculated	
media	were	run	parallel	to	the	test	compounds	under	the	same	
conditions.	The	substance	that	had	no	visible	turbidity.	Control	
experiments	 with	 DMF	 and	 uninoculated	 media	 were	 run	
parallel	to	the	test	compounds	under	the	same	conditions.	
	
3.	Results	and	discussion		
	
3.1.	Chemistry	
	
In	this	work,	we	describe	generally	applicable	extension	of	
this	 synthetic	 approach,	 first	 was	 reported	 by	 Hantzsch	 and	
Weber	 [23].	 Thus,	 the	 base	 catalyzed	 reaction	 of	 the	 acidic	
methylene	compound	1	with	phenyl	isothiocyanate	in	dry	N,N‐
dimethylformamide	at	room	temperature	 in	basic	medium	led	
to	the	formation	of	the	non‐	isolable	intermediate	2	which	gave	
thiocarbamoylderivative3upon	 treatment	 with	 dilute	 HCl	
(Scheme	1).	
Assignment	 of	 the	product	3	was	based	on	 elemental	 and	
spectral	analysis.	The	IR	spectrum	showed	absorption	bands	at	
3403,	 3291,	 2185,	 1593	 and	 1233	 cm‐1	 attributable	 to	 the	
NHPh,	amidic	NH,	CN,	C=O	and	C=S	functions,	respectively.	 Its	
1H	 NMR	 spectrum	 revealed	 two	 singlet	 signals	 at	 δ	 3.84	 and	
4.25	ppm	for	CH	and	NHPh	protons,	multiplet	signals	at	δ	7.02‐
7.78	ppm	for	aromatic	protons	and	singlet	signal	at	δ	9.75	ppm	
for	NH	proton.	
Compound	3	 also	undergoes	cyclization	upon	 the	 reaction	
with	 phenacyl	 bromide	 in	 a	 mixture	 of	 ethanol	 and	 N,N‐
dimethylformamide	 (2:1)in	 presence	 of	 catalytic	 amount	 of	
triethylamine	yielded	a	product	4,	which	analyzed	correctly	for	
C42H28N6O2S2.	 The	 structure	 4	 was	 inferred	 from	 its	 correct	
spectral	data.	Thus,	the	IR	spectrum	showed	absorption	bands	
at	 3284,	 2170,	 1581	 and	1552	 cm‐1	 corresponding	 to	NH,	 CN,	
CO	 and	 C=C	 functions,	 respectively.	 Its	 1HNMR	 spectrum	
revealedsinglet	signal	at	δ	6.23	ppm	for	CH,	multiplet	signals	at	
δ	 7.23‐7.45	 ppm	 for	 aromatic	 protons	 and	 singlet	 signal	 at	 δ	
9.60	ppm	for	NH	proton.	The	structure	of	4	was	also	confirmed	
by	its	mass	spectrum	which	showed	the	molecular	ion	peak	at	
m/z	=	712	(M+,	90%)	corresponding	to	 the	molecular	 formula	
C42H28N6O2S2.	 Based	 on	 the	 forgoing	 data,	 structure	 4	 was	
assigned	to	this	product.	The	structure	4	was	further	confirmed	
by	 alternative	 synthesis.	 Thus,	 it	was	 found	 that,	 stirring	 of	2	
with	 phenacyl	 bromide	 in	 a	 mixture	 of	 ethanol	 and	 N,N‐
dimethylformamide	 (2:1)	 at	 room	 temperature	 afforded	 the	
acyclic	 intermediate	 5	 by	 HBr	 elimination.	 Structure	 5	 was	
suggested	 for	 the	 reaction	 product	 on	 the	 basis	 of	 both	
elemental	 and	 spectral	 analyses.	 The	 IR	 spectrum	 showed	
absorption	 bands	 at3295,	 2186,	 1649	 and	 1599	 cm‐
1corresponding	to	NH,	CN,	CO	and	C=C	functions,	respectively.	
Its	1H‐NMR	spectrum	revealed	two	singlet	signal	at	δ	3.72	and	
4.30	 ppm	 for	 NHPh	 and	 CH2,	 multiplet	 signals	 at	 δ	 7.23‐7.62	
ppm	for	aromatic	protons	and	singlet	signal	at	δ	9.70	ppm	for	
NH	proton.		
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The	 structure	 of	 compound	 5	 was	 confirmed	 also	 by	 its	
mass	spectrum	which	showed	a	peak	at	m/z	=	746	(M+‐2,	30%).	
Refluxing	 of	 compound	5	 in	N,N‐dimethylformamide	with	
few	 drops	 of	 triethylamineled	 to	 the	 formation	 of	 a	 product	
identical	in	all	respects	(M.p.,	mixed	m.p.,	IR	and	1H	NMR)	to	4	
(Scheme	2).	
When	 the	 compound	 3	 was	 treated	 with	 ethyl	
chloroacetate	or	with	ethyl	bromoacetate	or	with	chloroacetic	
acid	or	with	 chloroacetyl	 chloride	 in	a	mixture	of	 ethanol	and	
N,N‐dimethylformamide	(2:1)	with	few	drops	of	triethylamine	,	
a	product	7	that	analyzed	for	C30H20N6O4S2	was	isolated	in	each	
case	 in	 good	 yield.	 While,	 the	 reaction	 of	 the	 intermediate	2	
with	 ethyl	 chloroacetate	 or	 with	 ethyl	 bromoacetate	 or	 with	
chloroacetic	 acid	 in	 mixture	 of	 N,N‐dimethylformamide	 and	
ethanol	 (1:2)	 led	 to	 the	 formation	of	compound	6.	The	acyclic	
structure	 6	 was	 established	 based	 on	 its	 IR	 spectrum	 that	
showed	absorption	bands	at	3401,	3322,	2200,	1735,	1660	and	
1594	 cm‐1	 attributable	 to	 the	 NHPh,	 amidic	 NH,	 CN,	 COOEt,	
CONH	 and	 C=C	 functions,	 respectively.	 Its	 1H	 NMR	 spectrum	
revealed	triplet	signal	at	δ	1.21	ppm	for	CH3,	two	singlet	signals	
at	δ	3.92	and	4.00	ppm	for	NHPh	and	CH2S,	quartet	signal	at	δ	
4.18	 ppm	 for	 CH2,	 multiplet	 signals	 at	 δ	 7.06‐7.61	 ppm	 for	
aromatic	 protons	 and	 singlet	 signal	 at	 δ	 9.69	 ppm	amidic	NH	
protons.	 Refluxing	 of	 6	 in	 N,N‐dimethylformamide	 and	 a	
catalytic	 amount	 of	 triethylamine	 affordedthe	 corresponding	
thiazole	derivative	7.	Structure	7	was	confirmed	on	the	basis	of	
its	elemental	and	spectral	data.	The	IR	spectrum	showed	bands	
at	 3401,	 2194,	 1735	 and	 1656	 cm‐1attributable	 to	 the	 amidic	
NH,	 CN,	 CO	 and	 CONH	 functions,	 respectively.	 Its1HNMR	
spectrum	revealed	singlet	signal	at	δ	3.97	ppm	for	CH2	protons,	
multiplet	signals	at	δ	7.23‐7.55	ppm	for	aromatic	protons	and	
singlet	 signal	 at	 δ	 9.28	 ppm	 for	 NH	 proton.	 The	 structure	 of	
compound	7	was	 confirmed	 also	 by	 its	mass	 spectrum	which	
showed	a	peak	at	m/z	=	592	(M+,	90%).	
The	 intermediate	 2	 reacted	 with	 chloroacetyl	 chloride	 in	
stirring	N,N‐dimethylformamide	and	ethanol	(1:2),	a	product	8	
that	 analyzed	 for	 C30H22N6O4S2Cl2	 was	 isolated	 in	 good	 yield.	
The	 acyclic	 structure	 8	 was	 established	 based	 on	 its	 IR	
spectrum	 that	 showed	 bands	 at	 3408,	 3318,	 2194,	 1745	 and	
1655	 cm‐1	 related	 to	NHPh,	NH,	 CN,	 COCl	 and	CONH	 function	
groups,	respectively.	Its	1H	NMR	spectrum	revealed	two	singlet	
signals	 at	 δ	 3.82	 and	 4.00	 ppm	 for	 NHPh	 and	 CH2	 protons,	
multiplet	signals	at	δ	7.20‐7.63	ppm	for	aromatic	protons	and	
singlet	 signal	 at	 δ	 9.55	 ppm	 for	 amidic	 NH	 proton.	 The	
structure	of	compound	8	was	confirmed	by	its	mass	spectrum	
which	showed	a	peak	at	m/z	=	664	(M+,	50%).	
Refluxing	of	compound	8	 in	N,N‐dimethylformamide	and	a	
catalytic	 amount	 of	 triethylamine	 led	 to	 the	 formation	 of	 a	
product	 identical	 in	 all	 respects	 (M.p.,	 mixed	m.p.,	 IR	 and	 1H	
NMR	)	to	compound	7	(Scheme	3).	
Similarly,	 when	 the	 intermediate	 sodium	 salt	 2	 is	 stirred	
with	 chloroacetonitrile	 in	 a	 mixture	 of	 ethanol	 and	 N,N‐
dimethylformamide	(2:1)	at	room	temperature	the	correspond‐
ding	acyclic	intermediate	9	is	exclusively	isolated	in	good	yield.	
The	structure	of	9	has	been	confirmed	on	the	basis	of	elemental	
and	 spectral	 data.	 The	 IR	 spectrum	 exhibits	 bands	 at	 3407,	
2923,	2193,	1656	and	1606	cm‐1related	 to	 the	NHPh,	NH,	CN,	
CO	and	C=C	function	groups,	respectively.	Its	1H	NMR	spectrum	
revealed	 two	 singlet	 signals	 at	 δ	 3.90	 and	 4.11	 ppm	
corresponding	to	NHPh	and	CH2	protons,	multiplet	signals	at	δ	
7.02‐7.71	ppm	for	aromatic	protons	and	singlet	signal	at	δ	9.63	
ppm	corresponding	to	amidic	NH	proton.	The	correct	structure	
of	compound	9	was	also	confirmed	by	its	mass	spectrum	which	
showed	 a	 peak	 at	 m/z	 =	 591	 (M++1,	 20%).	 Furthermore,	
refluxing	 of	 the	 acyclic	 intermediate	 9	 in	 N,N‐dimethyl	
formamide	 containing	 a	 catalytic	 amount	 of	 triethylamine	
afforded	the	thiazole	derivative	10.	The	thiazole	derivative	10	
was	established	based	on	its	IR	spectrum	which	showed	bands	
at	3399,	2197	and	1650	cm‐1	related	to	the	amidic	NH,	CN	and	
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CO	 function	 groups,	 respectively.	 Its	 1H‐NMR	 spectrum	
revealed	two	singlet	signals	at	δ	1.21	and	4.11	ppm	forNH2	and	
CH	protons,	multiplet	signals	at	δ	7.02	‐7.56	ppm	for	aromatic	
protons	 and	 singlet	 signal	 at	 δ	 9.76	 ppm	 for	 NH	 proton.	 The	
correct	 structure	 of	 compound	10	 was	 also	 confirmed	 by	 its	
mass	spectrum	which	showed	a	peak	at	m/z	=	590	(M+,	78%).	
On	 the	 other	 hand,	 it	 has	 been	 found	 that	 compound	 10	 is	
directly	 formed	 by	 refluxing	 compound	 3	 with	 chloroaceto	
nitrile	 in	 a	 mixture	 of	 ethanol	 and	 N,N‐dimethylformamide	
(2:1)and	 in	 presence	 of	 catalytic	 amount	 of	 triethylamine	
(Scheme	4).	
Stirring	of	compound	2	with	chloroacetone	in	a	mixture	of	
ethanol	and	N,N‐dimethylformamide	(2:1)at	room	temperature	
to	afford	 the	acyclic	 intermediate	11	by	NaCl	elimination.	The	
acyclic	 intermediate	 11	 was	 established	 based	 on	 its	 IR	
spectrum	which	showed	bands	at	3279,	2924,	2184,	1723	and	
1644	 cm‐1	 corresponding	 to	 NH,	 CH,	 CN,	 COCH3	 and	 CONH	
function	 group,	 respectively.	 Its	 1H	 NMR	 spectrum	 revealed	
three	singlet	signals	at	δ	2.10	,	3.45	and	4.00	ppm	for	CH3	,	CH2	
and	 NHPh	 protons,	 multiplet	 signals	 at	 δ	 7.36	 ‐7.59	 ppm	 for	
aromatic	 protons	 and	 singlet	 signal	 at	 δ	 9.70	 foramidic	 NH	
proton.	Also,	its	mass	spectrum	showed	the	molecular	ion	peak	
at	 m/z	 =	 624	 (M+,	 60%)	 corresponding	 to	 the	 molecular	
formula	C32H28N6O4S2.	
Refluxing	 of	 compound	 11	 in	 N,N‐dimethylformamide	 in	
presence	 of	 catalytic	 amount	 of	 triethylamine	 gave	 the	
thiophene	derivative	12	whose	structure	was	confirmed	by	its	
alternative	 synthesis.	 Thus,	 refluxing	 of	 compound	 3	 with	
chloroacetone	 in	 a	 mixture	 of	 ethanol	 and	 N,N‐dimethyl	
formamide	 (2:1)	 in	 presence	 of	 catalytic	 amount	 of	
triethylamine	 afforded	 the	 thiophene	 derivative	 12	 in	
reasonably	good	yield.	The	structure	12	was	established	based	
on	its	IR	spectrum	that	showed	bands	at	3270,	2191,	1743	and	
1660	cm‐1	related	to	NH,	CN,	COCH3	and	CONH	function	groups,	
respectively.	The	1H	NMR	spectrum	of	the	thiophene	derivative	
12	revealed	two	singlet	signals	at	δ	2.50	and7.11	ppm	for	CH3	
and	NH2	protons,	multiplet	signals	at	δ	7.36‐7.63	ppm	and	two	
singlet	signals	at	δ	9.72	and	9.78	ppm	for	PhNH	and	amidic	NH	
protons.	 Also,	 its	 mass	 spectrum	 showed	 the	 molecular	 ion	
peak	at	m/z	 =	624	 (M+,	70%)	corresponding	 to	 the	molecular	
formula	C32H28N6O4S2	(Scheme	5).		
When	 the	 intermediate	 sodium	 salt	 2	 stirred	 with	 1,3‐
dibromopropane	in	N,N‐dimethylformamide	at	room	tempera‐
ture	 in	 alcoholic	 potassium	 hydroxide,	 a	 product	 13a	 that	
analyzed	 for	 C29H24N6O2S2	 was	 isolated	 in	 good	 yield.	 The	
structure	 13a	 was	 established	 based	 on	 its	 IR	 spectrum	 that	
showed	 bands	 at	 3303,	 3284,	 2925,	 2192	 and	 1660	 cm‐1	
corresponding	 to	 NHPh,	 amidic	 NH,	 CH2,	 CN	 and	 CO	 function	
groups,	 respectively.	 Its	 1H	NMR	 spectrum	 revealed	multiplet	
signals	at	δ	1.72‐1.93	ppm	attributable	 to	CH2	protons,	 triplet	
signal	at	δ	3.40	ppm	for	CH2S	protons,	 singlet	signal	at	δ	3.68	
ppm	for	NHPh	proton,	multiplet	signals	at	δ	7.21‐7.55	ppm	for	
aromatic	protons	and	singlet	signal	at	δ	9.56	ppm	foramidic	NH	
proton.	The	 structure	 of	 compound	13a	was	 confirmed	by	 its	
mass	 spectrum	 which	 showed	 a	 peak	 at	 m/z	 =	 558	 (M++6,	
90%).	
Similary,	 when	 the	 intermediate	 2	 was	 stirred	 with	 1,4‐
dibromobutane	 in	 N,N‐dimethylformamide	 at	 room	 tempe‐
rature	 in	 alcoholic	 potassium	 hydroxide,	 a	 product	 13b	 that	
analyzed	 for	 C30H26N6O2S2	 was	 isolated	 in	 good	 yield.	 The	
structure	13b	 was	 established	 based	 on	 its	 IR	 spectrum	 that	
showed	 bands	 at	 3280,	 2927,	 2194	 and	 1631	 cm‐1	 related	 to	
NH,	CH2,	CN	and	CO	function	groups,	 respectively.	 Its	 1H	NMR	
spectrum	 revealed	 multiplet	 signals	 at	 δ	 1.52‐1.75	 ppm	
attributable	 to	 CH2	 protons,	 triplet	 signal	 at	 δ	 3.40	 ppm	 for	
CH2S	 protons,	 singlet	 signal	 at	 δ	 4.10	 ppm	 for	 NHPh	 proton,	
multiplet	signals	at	δ	7.23‐7.43	ppm	for	aromatic	protons	and	
singlet	signal	at	δ	9.41	ppm	foramidic	NH	proton.	The	structure	
of	compound	13b	was	confirmed	by	 its	mass	spectrum	which	
showed	a	peak	at	m/z	=	569	(M++3,	89%).	
Moreover,	 the	 intermediate	 2	 when	 reacted	 with	 1,2‐
bis(bromomethyl)benzene	 in	 stirring	 N,N‐dimethylformamide	
at	 room	 temperature	 in	 alcoholic	 potassium	 hydroxide,	 a	
product	14	that	analyzed	for	C34H26N6O2S2	was	isolated	in	good	
yield.	 The	 structure	 14	 was	 established	 based	 on	 its	 IR	
spectrum	 that	 showed	 bands	 at	 3401,	 3259,	 2925,	 2192	 and	
1660	 cm‐1	 due	 to	 NHPh,	 amidic	NH,	 CH2,	 CN	 and	 CO	 function	
groups,	 respectively.	 Its	 1H	 NMR	 spectrum	 revealed	 a	 singlet	
signal	 at	 δ	 3.86	 ppm	 attributable	 to	 CH2S	 protons,	 multiplet	
signals	at	δ	7.14‐7.40	ppm	for	aromatic	protons	and	two	singlet	
signal	at	δ	9.51	and	11.65	ppm	for	NHPh,	amidic	NH	protons.	
Its	mass	spectrum	showed	a	peak	at	m/z	=	614	(M+,	91%).	
In	 addition	 to	 that	 mentioned	 above,	 refluxing	 the	
intermediate	 2	 with	 6‐chloro‐2,4‐diamino	 pyrimidine	 in	 a	
mixture	 of	 N,N‐dimethylformamide	 and	 acetone	 (1:2)	 in	
presence	of	potassium	carbonate	yielded	a	product	15,	which	
analyzed	 correctly	 for	 C34H28N14O2S2.	 The	 structure	 15	 was	
inferred	 from	 its	 spectral	 data.	 Thus,	 IR	 spectrum	 showed	
absorption	 bands	 at	 3397,	 3315,	 3282,	 3195,	 2192	 and	 1644	
cm‐1	 corresponding	 to	 two	NH2,	NHPh,	 amidic	NH,	CN	and	CO	
functions,	 respectively.	 Its	 mass	 spectrum	 showed	 a	 peak	 at	
m/z	=	724	(M+‐4,	73%)	(Scheme	6).	
	
3.2.	Antimicrobial	activity		
	
Fifteen	 of	 newly	 synthesized	 target	 compounds	 were	
evaluated	for	their	in	vitro	antibacterial	activity	against	Bacillus	
subtilis	 and	Bacillus	 thuringiensis	 as	 example	of	Gram‐positive	
bacteria	 and	 Escherichia	 coli	 and	 pseudomonas	 aeruginosa	 as	
examples	of	Gram‐negative	bacteria.	They	were	also	evaluated	
for	 their	 in	 vitro	 antifungal	 potential	 against	 Fusarium	
oxysporum	and	Botrytis	fabae	fungal	strains.	
Agar‐diffusion	method	was	 used	 for	 the	 determination	 of	
the	 preliminary	 antibacterial	 and	 antifungal	 activity.	
Chloramphenicol,	cephalothin	and	cycloheximide	were	used	as	
reference	 drugs.	 The	 results	 were	 recorded	 for	 each	 tested	
compound	 as	 the	 average	diameter	of	 inhibition	 zones	 (IZ)	of	
bacterial	 or	 fungal	 growth	 around	 the	 disks	 in	 mm.	 The	
minimum	 inhibitory	 concentration	 (MIN)	 measurement	 was	
determined	 for	 compounds	 showed	 significant	 growth	
inhibition	 zones	 (>14	 mm)	 using	 two	 fold	 serial	 dilution	
method	 [24].	The	MIC	 (µg/mL)	and	 inhibition	zone	diameters	
values	are	recorded	in	Table	1.		
The	 results	 depicted	 in	 Table	 1	 revealed	 that	 the	most	 of	
tested	 compounds	displayed	variable	 inhibitory	effects	on	 the	
growth	 of	 the	 tested	 Gram‐positive	 and	 Gram‐negative	
bacterial	 strains,	 and	also	against	 antifungal	 strain.	 In	 general	
most	of	 the	 tested	compounds	revealed	better	activity	against	
the	Gram‐positive	rather	than	the	Gram‐negative	bacteria.	
Regarding	 the	 structure‐activity	 relationship	 of	 the	
thiazoles	derivatives	against	Gram‐positive	bacteria,	the	results	
revealed	 that	 compounds	 4,	 7,	 14	 and	 15	 exhibited	 broad	
spectrum	 antibacterial	 profile	 against	 the	 tested	 organisms.	
Thiazoles	 derivatives	 4	 and	 7	 recorded	 higher	 activity	 than	
thiophene	derivative	12.	In	this	view,	compounds	4,	7,	14,	and	
15	 were	 equipotent	 to	 chloramphenicol	 in	 inhibiting	 the	
growth	of	B.	subtilis	 (MIC	3.125	µg/mL),	while	 its	activity	was	
50%	 lower	 than	 of	 chloramphenicol	 against	 B.	 thuringiensis.	
Compound	12	showed	50%	of	 the	activity	of	chloramphenicol	
(MIC	 6.25	 µg/mL)	 but	 it	 was	 equipotent	 to	 cephalothin	 in	
inhibiting	 the	 growth	 of	 B.	 subtilis	 and	 B.	 thuringiensis	 (MIC	
6.25	µg/mL).	On	the	other	hand,	compounds	1,	3,	5,	6,	8,	9,11,	
13a	 and	 13b	 exhibited	 moderate	 growth	 inhibitory	 activity	
against	 Gram‐positive	 bacteria	 as	 revealed	 from	 their	 MIC	
values	(6.25‐50	µg/mL).	Among	these	compounds	13a	and	13b	
showed	 good	 growth	 inhibitory	 against	 B.	 subtilis	 (MIC	 6.25	
µg/mL),	while	compounds	5,	6,	8,	9	and	11	showed	relatively	
good	 growth	 inhibitory	 profiles	 against	 B.	 subtilis	 (MIC	 12.5	
µg/mL)	which	were	about	25%	of	the	activity	chloramphenicol	
and	50%	cephalothin	against	the	same	organism.	
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Table	1.	Minimal	inhibitory	concentration	(MIC,	µg/mL)	and	inhibition	zone	(mm)	of	some	new	synthesized	compounds	*.	
MIC	in	µg/mL,	and	inhibition	(mm)Compound	no	
FungiBacteria	
Gram‐negative	bacteriaGram‐positive	bacteria	
B.	fabae	F.	oxysporum	P.	aeruginosa	E.	coli	B.	thuringiensis	B.	subtilis 
50	(18)100	(16) 50	(19) 100	(15) 50	(14) 50	(18) 1 
100	(16)50	(19)	100	(16)100	(15)50	(15)	25	(27)	3	
25	(27)100	(16)	12.5	(33)25	(25)6.25	(38)	3.125	(45)	4	
50	(20)12.5	(33)	50	(19)50	(20)50	(14)	12.5	(33)	5	
100	(16)25	(25)	100	(15)100	(15)50	(20)	12.5	(32)	6	
6.25	(19)	6.25	(38)	50	(20)	100	(14)	6.25	(37)	3.125	(44)	7	
100	(16)	25	(25)	100	(15)	100	(15)	50	(20)	12.5	(32)	8	
50	(20)50	(19)	100	(16)100	(15)50	(15)	12.5	(32)	9	
100	(16)	100	(16)	100	(15)	100	(14)	6.25	(30)	6.25	(38)	10	
100	(15)100	(15)	50	(19)100	(15)6.25	(38)	12.5	(32)	11	
12.5	(32)12.5	(33)	100	(15)100	(15)6.25	(37)	6.25	(37)	12	
100	(16)100	(15)	50	(19)100	(15)6.25	(37)	6.25	(38)	13a	
100	(16)100	(15)	50	(19)100	(15)6.25	(37)	6.25	(38)	13b	
100	(16)100	(15)	50	(19)100	(15)6.25	(37)	3.125	(40)	14	
100	(16)100	(15)	50	(19)100	(15)6.25	(38)	3.125	(41)	15	
NT	NT6.25	(38)6.25	(37)3.125	(44)	3.125	(44)	Chloramphenicol	
NT	NT6.25	(37)6.25	(38)6.25	(37)	6.25	(36)	Cephalothin	
3.125	(42)3.125	(43)	NTNTNT	NT	Cycloheximide	
*	MIC:	Minimal	inhibitory	concentration	values	with	SEM	=	0.02	(The	lowest	concentration	that	inhibited	the	bacterial	growth);	NT:	Not	tested.	
	
	
Concerning	 the	 antibacterial	 activity	 of	 the	 compound	 5	
revealed	 weak	 growth	 inhibitory	 against	 the	 tested	 Gram‐
negative	bacteria	(MIC	50	µg/mL).	
Regarding	 the	 activity	 of	 thiazole	 derivatives,	 against	
antifungal	 strains,	 the	 results	 revealed	 that	 compound	7	 was	
50%	 lower	 than	 cycloheximidein	 inhibitory	 the	 growth	 of	 B.	
fabae	and	F.	oxysporum	(MIC	6.25	µg/mL),	while	the	activity	of	
compound	 5	 and	 12	 were	 25%	 lower	 than	 cycloheximide	
against	F.	oxysporum	(MIC	12.5	µg/mL).		
The	 substituted	 pattern	 was	 also	 crucial.	 It	 is	 worth	
mentioning	 that	 formation	 of	 cyclic	 bisulphide	 and	 thiazole	
derivatives	produced	a	high	antimicrobial	activity.	On	the	other	
hand,	conversion	of	thiocarbamoyl	derivative	3	to	5,	6,	8,	9	and	
11	unfortunately	produced	weak	antimicrobial	activity.		
The	 tested	 compounds	 were	 more	 active	 against	 Gram‐
positive	than	Gram‐negative	bacteria,	it	may	be	concluded	that	
the	 antimicrobial	 activity	 of	 the	 compounds	 is	 related	 to	 cell	
wall	structure	of	the	bacteria.	It	is	possible	because	the	cell	wall	
is	essential	to	survival	of	bacteria	and	some	antibiotics	are	able	
to	 kill	 bacteria	 by	 inhibiting	 a	 step	 in	 the	 synthesis	 of	
peptidoglycan.	Gram‐positive	bacteria	possess	a	thick	cell	wall	
containing	many	layers	of	peptidoglycan	and	teichoic	acids,	but	
in	 contrast,	 Gram‐negative	 bacteria	 have	 a	 relatively	 thin	 cell	
wall	consisting	of	a	few	layers	of	peptidoglycan	surrounded	by	
a	 second	 lipid	 membrane	 containing	 lipopolysaccharides	 and	
lipoproteins.	 These	 differences	 in	 cell	 wall	 structure	 can	
produce	 differences	 in	 antibacterial	 susceptibility	 and	 some	
antibiotics	can	kill	only	Gram‐positive	bacteria	and	are	inactive	
against	Gram‐negative	pathogens	[25].	
	
4.	Conclusion	
	
The	present	study	describes	the	synthesis	and	investigates	
the	 antimicrobial	 activities	 of	 some	 new	 functionalized	
thiazoles,	thiophene	and	cyclic	dithio	derivatives	with	the	hope	
of	 discovering	 new	 structure	 leads	 serving	 as	 antimicrobial	
agents.		
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